Latest news with #MemorialCareHeart&VascularInstitute
Malaysian Reserve
6 days ago
- Business
- Malaysian Reserve
MemorialCare Heart & Vascular Institute Completes First Successful TriClip Procedure for Tricuspid Valve Repair
LONG BEACH, Calif., June 4, 2025 /PRNewswire/ — The cardiology team at the MemorialCare Heart & Vascular Institute at Long Beach Medical Center, led by Chief of Cardiology David Shavelle, M.D., performed Long Beach Medical Center's first transcatheter tricuspid valve replacement procedure using a new, innovative treatment option – the transcatheter edge-to edge repair (TEER) TriClip G4 System in September of 2024. The FDA-approved TriClip is a small clipping device designed to clip two or more of the leaflets of the tricuspid, offering a minimally invasive treatment option to patients who have tricuspid regurgitation (TR) – a condition where the tricuspid valve does not close completely when the right ventricle contracts. This device – implanted via a catheter inserted in the vein of the leg – helps reduce tricuspid regurgitation and promotes an immediate improvement in blood flow and allows patients to benefit from a less traumatic procedure and a faster recovery. This advanced technology marks a new era for treating tricuspid valve disease since prior to its introduction, patients could only receive a device better suited for the mitral valve (MitraClip® device). The TriClip device was specifically made for the tricuspid valve. In a large clinical trial, the device was shown to reduce symptoms and hospitalization for heart failure for patients at high-risk for open-heart surgery. 'This new procedure represents a significant advancement in our ability to treat high-risk patients with tricuspid valve heart disease,' says Dr. Shavelle, who led the landmark procedure. 'Historically there wasn't much we could do for those who still had symptoms after tricuspid regurgitation treatment and who were at high-risk for open heart surgery. This device gives patients access to improved quality of life.' This procedure was performed by a highly skilled, diverse team of cardiologists, cardiac surgeons, cardiac anesthesiologists and advanced imaging specialists from the MemorialCare Heart & Vascular Institute at Long Beach Medical Center. Implantation of the TriClip with the TriClip G4 System is as effective as open-heart surgery, helping patients return to their daily lives in one to two days. 'The patient recovered in the hospital for about two days, and he was able to return to his daily life the following day,' says Dr. Shavelle. 'It's amazing to see the positive impact this device has on our patients, allowing them to return to their daily lives with improved heart function and overall well-being.' The patient who received this procedure, Anthony Williams, reported being fatigued constantly with excessive swelling of the legs (edema) before the procedure. Today, he is more energetic than ever and ready to take on each day. MemorialCare Heart & Vascular Institute at Long Beach Medical Center is the first institute in the region to use this device and continues to lead in cardiovascular innovations, bringing patients with the latest technology advancements. As one of the most high performing hospitals according to U.S. News, MemorialCare Long Beach Medical Center is a six-time five-star recipient recognized for its excellence in cardiac care by Healthgrades, and has recently received the American Heart Association's Get With The Guidelines® Heart Failure Gold Plus Quality Achievement Award, as well as the American Heart Association/American Stroke Association's Get With The Guidelines® Stroke Gold Plus Quality Achievement Award. With these achievements and offering a comprehensive range of services for patients with cardiac disorders, including rehabilitation programs, Long Beach Medical Center is a community hospital dedicated in providing expert and compassionate care on par with those found in academic settings. About MemorialCare Long Beach Medical Center: MemorialCare Long Beach Medical Center is a member of MemorialCare, a not-for-profit, integrated healthcare system. Long Beach Medical Center has been providing the community with compassionate, quality health care for more than 100 years. At the forefront of specialized care, research, and education, Long Beach Medical Center uses the most advanced healthcare technologies, including pioneering surgical systems like – ExactechGPS® and ExcelsiusGPS®. Recognized among the top 3% of all California acute care hospitals, Long Beach Medical Center is recognized as 'Best Hospital' for OBGYN and Orthopedics and ranked regionally in the Los Angeles Metro Area by U.S. News & World Report and earned Magnet® recognition for nursing excellence. With premier centers dedicated to cancer, heart, rehabilitation, orthopedics, neurosciences, and trauma, physicians and surrounding hospitals continually refer to its accredited programs. For more information, visit
Yahoo
6 days ago
- Business
- Yahoo
MemorialCare Heart & Vascular Institute Completes First Successful TriClip Procedure for Tricuspid Valve Repair
LONG BEACH, Calif., June 4, 2025 /PRNewswire/ -- The cardiology team at the MemorialCare Heart & Vascular Institute at Long Beach Medical Center, led by Chief of Cardiology David Shavelle, M.D., performed Long Beach Medical Center's first transcatheter tricuspid valve replacement procedure using a new, innovative treatment option – the transcatheter edge-to edge repair (TEER) TriClip G4 System in September of 2024. The FDA-approved TriClip is a small clipping device designed to clip two or more of the leaflets of the tricuspid, offering a minimally invasive treatment option to patients who have tricuspid regurgitation (TR) – a condition where the tricuspid valve does not close completely when the right ventricle contracts. This device – implanted via a catheter inserted in the vein of the leg – helps reduce tricuspid regurgitation and promotes an immediate improvement in blood flow and allows patients to benefit from a less traumatic procedure and a faster recovery. This advanced technology marks a new era for treating tricuspid valve disease since prior to its introduction, patients could only receive a device better suited for the mitral valve (MitraClip® device). The TriClip device was specifically made for the tricuspid valve. In a large clinical trial, the device was shown to reduce symptoms and hospitalization for heart failure for patients at high-risk for open-heart surgery. "This new procedure represents a significant advancement in our ability to treat high-risk patients with tricuspid valve heart disease," says Dr. Shavelle, who led the landmark procedure. "Historically there wasn't much we could do for those who still had symptoms after tricuspid regurgitation treatment and who were at high-risk for open heart surgery. This device gives patients access to improved quality of life." This procedure was performed by a highly skilled, diverse team of cardiologists, cardiac surgeons, cardiac anesthesiologists and advanced imaging specialists from the MemorialCare Heart & Vascular Institute at Long Beach Medical Center. Implantation of the TriClip with the TriClip G4 System is as effective as open-heart surgery, helping patients return to their daily lives in one to two days. "The patient recovered in the hospital for about two days, and he was able to return to his daily life the following day," says Dr. Shavelle. "It's amazing to see the positive impact this device has on our patients, allowing them to return to their daily lives with improved heart function and overall well-being." The patient who received this procedure, Anthony Williams, reported being fatigued constantly with excessive swelling of the legs (edema) before the procedure. Today, he is more energetic than ever and ready to take on each day. MemorialCare Heart & Vascular Institute at Long Beach Medical Center is the first institute in the region to use this device and continues to lead in cardiovascular innovations, bringing patients with the latest technology advancements. As one of the most high performing hospitals according to U.S. News, MemorialCare Long Beach Medical Center is a six-time five-star recipient recognized for its excellence in cardiac care by Healthgrades, and has recently received the American Heart Association's Get With The Guidelines® Heart Failure Gold Plus Quality Achievement Award, as well as the American Heart Association/American Stroke Association's Get With The Guidelines® Stroke Gold Plus Quality Achievement Award. With these achievements and offering a comprehensive range of services for patients with cardiac disorders, including rehabilitation programs, Long Beach Medical Center is a community hospital dedicated in providing expert and compassionate care on par with those found in academic settings. About MemorialCare Long Beach Medical Center: MemorialCare Long Beach Medical Center is a member of MemorialCare, a not-for-profit, integrated healthcare system. Long Beach Medical Center has been providing the community with compassionate, quality health care for more than 100 years. At the forefront of specialized care, research, and education, Long Beach Medical Center uses the most advanced healthcare technologies, including pioneering surgical systems like – ExactechGPS® and ExcelsiusGPS®. Recognized among the top 3% of all California acute care hospitals, Long Beach Medical Center is recognized as "Best Hospital" for OBGYN and Orthopedics and ranked regionally in the Los Angeles Metro Area by U.S. News & World Report and earned Magnet® recognition for nursing excellence. With premier centers dedicated to cancer, heart, rehabilitation, orthopedics, neurosciences, and trauma, physicians and surrounding hospitals continually refer to its accredited programs. For more information, visit View original content to download multimedia: SOURCE MemorialCare Long Beach Medical Center
Los Angeles Times
05-05-2025
- Health
- Los Angeles Times
Treating the Heart Without the Need for Open Heart Surgery
With significant advancements in heart treatment, the days of open-heart surgery as the only option for complex heart conditions are mostly behind us. Today, minimally invasive procedures can be used in many cases, offering faster recovery times and fewer risks. While some emergent surgeries or life-saving measures may still require open-heart surgery, the majority of planned interventional procedures can be performed using a minimally invasive approach. At MemorialCare Heart & Vascular Institute, we encourage our patients to ask their cardiologist or primary care physician about minimally invasive options. Our team wants to raise awareness that patients have the right to ask for the best medicine has to offer. Interventional cardiology, often catheter-based, enables cardiologists to repair or correct a heart abnormality by creating a small incision at the groin and inserting a catheter up to the heart. Common heart abnormalities treated with interventional cardiology methods include mitral valve regurgitation and aortic valve stenosis. Mitral valve regurgitation is a common form of heart valve disease where the valve between the left heart chambers does not close completely, causing blood to leak backward across the valve. If this leak is severe, it could lead to heart failure - this means the heart cannot pump enough blood for the body's needs. To treat mitral valve regurgitation and prevent future heart failure, patients can receive a life-changing non-surgical, minimally invasive procedure – transcatheter mitral valve repair (TMVR) – using the advanced MitraClipTM device. MitraClip is often recommended for patients with severe regurgitation who aren't good candidates for valve replacement surgery, due to age or other complications. The catheter leads the MitraClip device up to the mitral valve and pulls the mitral valve leaflets into better alignment so they can open and close more easily. By permanently implanting the device to hold these leaflets together, the MitraClip effectively reduces the backflow of blood and helps restore proper valve function. This improved closure of the valve can alleviate symptoms and reduce the workload on the heart, which improves overall heart function and quality of life. The MitraClip procedure offers notable advantages over traditional open-heart surgery; MitraClip is performed using smaller incisions and reduced trauma to the chest. This is especially significant for high-risk patients who might not be able to tolerate open-heart surgery due to age, underlying health issues or frailty. Another common condition that can be treated without open heart surgery is aortic valve stenosis. Aortic stenosis occurs when the valve between the heart's lower left chamber and the aorta is narrowed, preventing it from opening fully. This forces the heart to pump even harder to get blood to the rest of the body, and if left untreated, can lead to heart failure. Without timely intervention, this increased strain on the heart can significantly decrease quality of life and lead to life-threatening complications. One common minimally invasive treatment used to treat aortic valve stenosis is transcatheter aortic valve replacement (TAVR). This procedure is performed similarly to the MitraClip procedure – the surgeon inserts a catheter through the groin to the aortic valve. The new valve is expanded and placed inside the damaged valve so it can immediately take over the role of regulating blood flow. TAVR is another procedure beneficial for high-risk patients who might not be able to handle open-heart surgery due to age, underlying health issues or frailty. Benefits of TAVR include less pain, shorter hospitalization and recovery times, less scarring and reduced complications. Working alongside our community cardiologists, the award-winning MemorialCare Heart & Vascular Institute offers a comprehensive, multidisciplinary, team-based approach to the evaluation and treatment of all heart conditions – from common to complex. For every patient's case, we provide minimally invasive approaches to give them the best outcome and quality of life. Our team collaborates for each patient's case to create an individualized plan of care. Want to learn more about interventional heart treatments? Visit or call (844) 662-6484. By: David Shavelle, M.D., chief of cardiology, MemorialCare Heart & Vascular Institute and Adult Cardiology & Interventional Lab Medical Director at Long Beach Medical Center
